Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Chronoscale Corp

CHRN ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Mid Cap Analyst: BUY

Last Close

$22.57

▼ -5.35%

Market Cap $3.29B · Vol 35.42K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.29B

Mid Cap

Div Yield

N/A

EPS Growth

+97.96%

YoY

RSI (14)

42.90

Momentum

Beta

1.01

vs Market

52W High

$30.00

24.77% below

52W Low

$3.51

543.02% above

Volume

35.42K

Avg 62.19K

P/B

14.98

Price-to-book

ROE

N/A

Return on equity

Free Float

2.46%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Chronoscale Corp (CHRN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CHRN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.71%

+4.98%

+45.75%

+121.93%

YTD

+161.23%

+535.77%

+55.12%

-66.78%

Financials & Valuation

TTM · Annual

Total Revenue	$12.80M
Net Income	$-11,695,000.00
Revenue Growth (YoY)	N/A
Gross Margin	-23.86%
Operating Margin	-177.07%
Net Profit Margin	-68.85%
ROE	N/A
ROA · ROIC	-50.02% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	35.56
P/B	14.98
P/FCF	208.88
EPS Growth	+97.96%
Outstanding Shares	145.64M

Technical Indicators

50-Day SMA	$21.95
200-Day SMA	$12.94
RSI (14)	42.90
Beta	1.01
52-Week High	$30.00
52-Week Low	$3.51

Volume Today	35.42K
Avg Daily Volume (30D)	62.19K
Relative Volume	0.57x
Volatility (10D)	59.39
Volatility (30D)	139.50
Free Float	2.46%

Analyst Consensus

BUY

Current Price $22.57

Mean Target $9.50

52W Low$3.51 52W High$30.00

Current

Target

$3.51 $30.00

Current Analyst target

-57.91% downside risk · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG002Z0NL95

ISINUS1709241046

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateJul 30, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -0.08% DHR Danaher Corp -1.71% ISRG Intuitive Surgical Inc -1.38% BSX Boston Scientific Corp -2.70% SHL.DE Siemens Healthineers AG +0.47%

Company Profile

ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.